BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34967534)

  • 21. New developments in non-Hodgkin lymphoid malignancies.
    Ganapathi KA; Brown LE; Prakash S; Bhargava P
    Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma.
    Mann G; Attarbaschi A; Burkhardt B; Niggli F; Klapper W; Ludwig WD; Schrappe M; Zimmermann M; Gadner H; Reiter A;
    Br J Haematol; 2007 Nov; 139(3):443-9. PubMed ID: 17868047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal non-Hodgkin's lymphoma. A population-based clinicopathological study of 111 adult cases with a follow-up of 10-15 years.
    Franssila KO; Jaser N; Sivula A
    APMIS; 1993 Aug; 101(8):631-41. PubMed ID: 8217115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel targeted therapies of T cell lymphomas.
    Iżykowska K; Rassek K; Korsak D; Przybylski GK
    J Hematol Oncol; 2020 Dec; 13(1):176. PubMed ID: 33384022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years.
    Au WY; Ma SY; Chim CS; Choy C; Loong F; Lie AK; Lam CC; Leung AY; Tse E; Yau CC; Liang R; Kwong YL
    Ann Oncol; 2005 Feb; 16(2):206-14. PubMed ID: 15668271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.
    Brice P; Cazals D; Mounier N; Verola O; Neidhart-Berard AM; Remenieras L; Deconinck E; Doyen C; Hamelsand J; Molina T; Moulonguet I; Gisselbrecht C
    Leukemia; 1998 Feb; 12(2):213-9. PubMed ID: 9519784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphoma of the Lacrimal Gland - An International Multicenter Retrospective Study.
    Vest SD; Mikkelsen LH; Holm F; Rasmussen PK; Hindso TG; Knudsen MKH; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Mulay K; Sjö LD; Sniegowski MC; Vemuganti GK; Thuro BA; Heegaard S
    Am J Ophthalmol; 2020 Nov; 219():107-120. PubMed ID: 32574779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas.
    Hur JY; Kim YJ; Yoon SE; Son DS; Park WY; Kim SJ; Park D; Kim WS
    Ann Hematol; 2020 Jun; 99(6):1293-1302. PubMed ID: 32296914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recommendations on prevention of infections in patients with T-cell lymphomas: a narrative review and synthesis.
    Reynolds G; Anderson MA; Thursky K; Teh BW; Slavin MA
    Leuk Lymphoma; 2023 Dec; 64(13):2057-2070. PubMed ID: 37688482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological study on peripheral T-cell non-Hodgkin lymphoma with bone marrow involvement: a retrospective analysis from China.
    Tong H; Ren Y; Qian W; Xiao F; Mai W; Meng H; Jin J
    Int J Hematol; 2009 Oct; 90(3):303-310. PubMed ID: 19728028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico.
    Hernandez-Ruiz E; Alvarado-Ibarra M; Juan Lien-Chang LE; Banda-Garcia L; Aquino-Salgado JL; Barragan-Ibanez G; Ramirez-Romero EF; Nolasco-Cancino C; Herrera-Olivares W; Morales-Adrian JJ; Paredes-Lozano EP; Espitia-Rios ME; Gonzalez Lopez-Elizalde MM; Lopez-Arroyo JL; Trejo-Gomora JE; De la Pena-Celaya JA; Alvarez-Vera JL; Arana-Luna LL; Martinez-Rios A; Resendiz-Olea R; Rodriguez-Velasquez LJ; Zapata-Canto N; Perez-Zuniga JM
    World J Oncol; 2021 Feb; 12(1):28-33. PubMed ID: 33738003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinicopathological analysis of primary intestinal non-Hodgkin's lymphoma: a report of 32 cases].
    Yang D; Bai CM; Xiao Y; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):445-8. PubMed ID: 15498216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracorporeal photophoresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Non-Hodgkin Lymphoma Pathologic Classification Project. Long-term follow-up of 1153 patients with non-Hodgkin lymphomas.
    Simon R; Durrleman S; Hoppe RT; Bonadonna G; Bloomfield CD; Rudders RA; Cheson BD; Berard CW
    Ann Intern Med; 1988 Dec; 109(12):939-45. PubMed ID: 3057985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosis.
    de Bruin PC; Noorduyn AL; van der Valk P; van Heerde P; van Diest PJ; van de Sandt MM; Ossenkoppele GJ; Meijer CJ
    Cancer; 1993 Apr; 71(8):2604-12. PubMed ID: 8453584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features.
    Møller MB; Nielsen O; Pedersen NT
    Am J Clin Pathol; 2001 Mar; 115(3):404-12. PubMed ID: 11242797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults.
    Magrath IT; Janus C; Edwards BK; Spiegel R; Jaffe ES; Berard CW; Miliauskas J; Morris K; Barnwell R
    Blood; 1984 May; 63(5):1102-11. PubMed ID: 6546890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and prognostic factors for head and neck non-Hodgkin's lymphoma in Chinese patients.
    Wang J; Cai CP; He SF; Wang SL
    J Laryngol Otol; 2013 Jul; 127(7):699-704. PubMed ID: 23738972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.
    Ko YH; Kim CW; Park CS; Jang HK; Lee SS; Kim SH; Ree HJ; Lee JD; Kim SW; Huh JR
    Cancer; 1998 Aug; 83(4):806-12. PubMed ID: 9708949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.